Loading clinical trials...
Loading clinical trials...
Prospective, Observational Study to Assess Migraine Prediction Tool Based on Prodromal Symptoms and Additional Parameters
Conditions
Interventions
Daily questionnaire
Locations
3
United States
Westport Headache Institute
Westport, Connecticut, United States
Headache Neurology Research Institute
Ridgeland, Mississippi, United States
Nuvance Health Vassar Medical Center
Poughkeepsie, New York, United States
Start Date
January 1, 2030
Primary Completion Date
October 1, 2030
Completion Date
November 15, 2030
Last Updated
November 22, 2024
NCT07018713
NCT06641466
NCT04715685
NCT07476053
NCT05734625
NCT06616194
Lead Sponsor
Theranica
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions